| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Hydroxy Saxagliptin |
|
841302-24-7 |
詳細
|
| Hydroxydimetridazole in methanol |
羥甲基甲硝咪唑 |
936-05-0 |
詳細
|
| Hydroxyzine pamoate in DMSO |
|
10246-75-0 |
詳細
|
| Hydroxy Tyrosol (>98%, Synthetic) |
羥基酪醇 |
10597-60-1 |
詳細
|
| Hygromycin A |
|
6379-56-2 |
詳細
|
| Hypothemycin |
|
76958-67-3 |
詳細
|
| Hydroxychloroquine |
2-[[4-[(7-氯喹啉-4-基)氨基]戊基](乙基)氨基]乙醇 |
118-42-3 |
詳細
|
| Hygromycin B in methanol |
乙腈/水中潮霉素 B |
31282-04-9 |
詳細
|
| Hydroxymetronidazole in acetonitrile |
乙腈中羥基甲硝唑 |
4812-40-2 |
詳細
|
| Hydroxythiovardenafil |
|
912576-30-8 |
詳細
|
| Hydroxychloroquine sulfate in methanol |
|
747-36-4 |
詳細
|
| Hyponine D |
|
259823-31-9 |
詳細
|
| ITAC/CXCL11, Human(HEK 293-expressed) |
|
|
詳細
|
| HYDROXYCHALCONE,2-(AS) |
|
644-78-0 |
詳細
|
| Hydroxymethyl Uracil |
|
4433-40-3 |
詳細
|
| Hythiemoside A |
|
853267-91-1 |
詳細
|
| Hymenialdisine Methanoate |
|
|
詳細
|
| Hypotaurine |
|
300-84-5 |
詳細
|
| Hydroxycitric Acid Tripotassium Salt Monohydrate |
HYDROXYCITRIC ACID POTASSIUM SALT,(-)-(P-基準級) |
232281-44-6 |
詳細
|
| Hydroxy Terbinafine β-D-Glucuronide |
|
99473-12-8 |
詳細
|
| Hydroxyethylcellulose CRS/A1A |
|
|
詳細
|
| Ibotenic acid in methanol |
|
2552-55-8 |
詳細
|
| Icariside I |
淫羊藿次苷I/黃酮 |
56725-99-6 |
詳細
|
| ICI 118551 Hydrochloride |
|
72795-01-8 |
詳細
|
| Icatibant (acetate) |
|
138614-30-9 |
詳細
|
| IBMX |
3-異丁基-1-甲基黃嘌呤 |
28822-58-4 |
詳細
|
| I-CBP112 Positive Control |
|
|
詳細
|
| ICR-1 AM |
|
|
詳細
|
| Ibiglustat |
|
1401090-53-6 |
詳細
|
| IDH-C227 |
|
1355324-14-9 |
詳細
|
| MK 677 |
|
159752-10-0 |
詳細
|
| Ifenprodil (hemitartrate) |
|
23210-58-4 |
詳細
|
| ICBA |
|
1207461-57-1 |
詳細
|
| ID-8 |
|
147591-46-6 |
詳細
|
| IDENTIFICATION OF MEDICINAL PLANTS |
|
|
詳細
|
| ICA 110381 |
|
325457-99-6 |
詳細
|
| IGF-I, Rat |
|
|
詳細
|
| IHH, Human |
|
|
詳細
|
| IL-17A, Mouse |
|
|
詳細
|
| IKK-16 Hydrochloride |
|
1186195-62-9 |
詳細
|
| iFSP1 |
|
150651-39-1 |
詳細
|
| iHAP1 |
|
105925-39-1 |
詳細
|
| IL-11, Human(CHO-expressed) |
|
|
詳細
|
| IGF-I (N-Met), Human |
|
|
詳細
|
| IGF-I, Human |
|
|
詳細
|
| IGF-BP-2, His, Human |
|
|
詳細
|
| IL-10, Human(CHO-expressed) |
|
|
詳細
|
| IL-5, Rat |
|
|
詳細
|
| IL-4, Porcine |
|
|
詳細
|
| IL-1β, Rat |
|
|
詳細
|
| IL-1β, Porcine |
|
|
詳細
|
| IL-6, Human |
重組人IL-6蛋白 |
|
詳細
|
| IL-3, Human |
重組人IL-3蛋白 |
|
詳細
|
| IL-6, Rat (HEK 293-expressed) |
|
|
詳細
|
| IL-1β, Mouse |
|
|
詳細
|
| IL-19, Mouse |
|
|
詳細
|
| IL-5, Human(CHO-expressed) |
|
|
詳細
|
| Hypaconitine in methanol |
對照品/Hypaconitine/需提供證明 |
6900-87-4 |
詳細
|
| IL-5, Mouse(CHO-expressed) |
|
|
詳細
|
| IL-4 R, Human |
|
|
詳細
|
| IL-7, His, Mouse |
|
|
詳細
|
| IL-3, Human(CHO-expressed) |
|
|
詳細
|
| IL-5 Rα, Human |
|
|
詳細
|
| IL-5, Human |
重組人IL-5蛋白 |
|
詳細
|
| IL-6, His, Mouse |
|
|
詳細
|
| IL-3, His, Rat |
|
|
詳細
|
| IL-1β, Rat (HEK 293-expressed) |
|
|
詳細
|
| IL-4, His, Rat |
|
|
詳細
|
| IL-21, Mouse |
|
|
詳細
|
| IL-2 R α, His, Human |
|
|
詳細
|
| IL-1β, Human(CHO-expressed) |
|
|
詳細
|
| IL-1β, Mouse(CHO-expressed) |
|
|
詳細
|
| IL-12, His, Rat |
|
|
詳細
|
| IL-15, His, Human |
|
|
詳細
|
| IL-13, Human(CHO-expressed) |
|
|
詳細
|
| IL-10, Mouse(CHO-expressed) |
|
|
詳細
|
| IL-12, Mouse |
|
|
詳細
|
| IL-1 RA, Human(HEK 293-expressed) |
|
|
詳細
|
| IL-18 BP, Human |
|
|
詳細
|
| IgG |
人β乳糖蛋白抗體IgG ELISA試劑盒 |
|
詳細
|
| IFN-γ, Mouse |
|
|
詳細
|
| IFN-α 1b, Human |
|
|
詳細
|
| IFN-α 2b, Human |
|
|
詳細
|
| Idarubicin-d3 |
|
|
詳細
|
| ICAAc |
|
|
詳細
|
| Hydroxypyruvic Acid Phosphate Barium Salt (>90%) |
|
114887-36-4 |
詳細
|
| Hydroxyethyl laurate |
|
|
詳細
|
| Hydroxychloroquine O-Sulfate (sodium salt) |
|
|
詳細
|
| Hydroxythiohomo Sildenafil |
羥基硫代豪莫西地那非 |
479073-82-0 |
詳細
|
| Hydroxyethoxyethyl oleate |
|
106-12-7 |
詳細
|
| Hydroxychloroquine for system suitability CRS/A1A |
|
|
詳細
|
| Ibandronate sodium monohydrate CRS/A1A |
|
|
詳細
|
| I-309/CCL1, Human(CHO-expressed) |
|
|
詳細
|
| Hypoglycine B |
|
502-37-4 |
詳細
|
| HYDROXYCITRIC ACID LACTONE,(-)-(P) |
|
27750-13-6 |
詳細
|
| IL-4, Human |
重組人IL-4蛋白 |
|
詳細
|
| ICM Kit, native and labelled |
|
|
詳細
|
| IC87201 |
化學試劑/IC87201 |
866927-10-8 |
詳細
|
| Hyoscine butylbromide for system suitability CRS/A1A |
|
|
詳細
|
| IL-4, Mouse |
|
|
詳細
|